✓ No loaded language, vague sourcing, or framing detected.
The FDA has approved Rextovy, a 4 milligram naloxone nasal spray, making it the third over-the-counter version available for the emergency treatment of opioid overdose. This product will be accessible for purchase in various retail locations.
Our neutral summary
The FDA has approved Rextovy, a 4 milligram naloxone nasal spray, making it the third over-the-counter version available for the emergency treatment of opioid overdose. This product will be accessible for purchase in various retail locations.
The reporting belongs to The Hill; we don't reproduce it.
No note attached
on this article.
FDA approves third over-the-counter opioid overdose nasal spray
FDA Approves Third Over-the-Counter Naloxone Nasal Spray